• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

On the tightrope between life and graft: immunosuppression in critically ill solid organ transplant recipients.

作者信息

Azoulay Elie

机构信息

Intensive Care Department, APHP, Saint-Louis Hospital, Paris-Cité University, Paris, France.

INSERM UMR1342 Institut de Recherche Saint-Louis, Paris, France.

出版信息

Intensive Care Med. 2025 Sep;51(9):1699-1702. doi: 10.1007/s00134-025-08061-2. Epub 2025 Aug 19.

DOI:10.1007/s00134-025-08061-2
PMID:40828462
Abstract
摘要

相似文献

1
On the tightrope between life and graft: immunosuppression in critically ill solid organ transplant recipients.在生命与移植的钢丝绳上：危重症实体器官移植受者的免疫抑制
Intensive Care Med. 2025 Sep;51(9):1699-1702. doi: 10.1007/s00134-025-08061-2. Epub 2025 Aug 19.
2
Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients.提高实体器官移植受者免疫抑制剂药物依从性的干预措施。
Cochrane Database Syst Rev. 2022 Sep 12;9(9):CD012854. doi: 10.1002/14651858.CD012854.pub2.
3
Novel association between graft rejection and post-transplant malignancy in solid organ transplantation.实体器官移植中移植排斥与移植后恶性肿瘤之间的新型关联。
World J Transplant. 2025 Jun 18;15(2):102384. doi: 10.5500/wjt.v15.i2.102384.
4
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
5
Recipient donor sex combinations in solid organ transplantation and impact on clinical outcome: A scoping review.实体器官移植中受者供者性别组合与临床结局的关系：范围综述。
Clin Transplant. 2024 May;38(5):e15312. doi: 10.1111/ctr.15312.
6
Squamous and basal skin cancers in 17,207 solid organ transplant recipients: Real-world data from national health insurance database in Poland.17207例实体器官移植受者的鳞状和基底皮肤癌：来自波兰国家健康保险数据库的真实世界数据。
Adv Clin Exp Med. 2025 Jun;34(6):901-909. doi: 10.17219/acem/199653.
7
Impact of antiviral prophylaxis on EBV viremia and posttransplant lymphoproliferative disorders in solid organ transplant recipients: a systematic review and meta-analysis.抗病毒预防对实体器官移植受者EBV病毒血症及移植后淋巴细胞增生性疾病的影响：一项系统评价与荟萃分析
Virol J. 2025 Jan 15;22(1):11. doi: 10.1186/s12985-025-02623-y.
8
COVID-19 and solid organ transplantation: Finding the right balance.COVID-19 与实体器官移植：寻找平衡。
Transplant Rev (Orlando). 2022 Jul;36(3):100710. doi: 10.1016/j.trre.2022.100710. Epub 2022 Jul 4.
9
Elexacaftor-tezacaftor-ivacaftor use after solid organ transplant.实体器官移植后使用依列卡福托-替扎卡福托-依伐卡托。
Curr Opin Pulm Med. 2024 Nov 1;30(6):660-666. doi: 10.1097/MCP.0000000000001110. Epub 2024 Jul 31.
10
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.抗 CMV 病的抗病毒药物用于预防实体器官移植受者。
Cochrane Database Syst Rev. 2024 May 3;5(5):CD003774. doi: 10.1002/14651858.CD003774.pub5.

本文引用的文献

1
Effect of temporary suspension of chronic immunosuppressive drugs on day-90 mortality and ICU-acquired infections among critically Ill patients with solid organ transplant: a retrospective multicenter study.实体器官移植重症患者中，慢性免疫抑制药物临时停用对90天死亡率及重症监护病房获得性感染的影响：一项回顾性多中心研究
Intensive Care Med. 2025 Aug;51(8):1442-1452. doi: 10.1007/s00134-025-08024-7. Epub 2025 Jul 16.
2
Immunosuppression minimization and withdrawal in liver transplantation: The "holy grail"?肝移植中免疫抑制的最小化与撤减：“圣杯”？
Transpl Immunol. 2025 Sep;92:102248. doi: 10.1016/j.trim.2025.102248. Epub 2025 Jun 2.
3
A critical assessment of corticosteroid trials for hospitalised patients with SARS-CoV-2 disease.
对SARS-CoV-2疾病住院患者进行的皮质类固醇试验的批判性评估。
Intensive Care Med. 2025 May;51(5):972-974. doi: 10.1007/s00134-025-07878-1. Epub 2025 May 23.
4
Causal inference can lead us to modifiable mechanisms and informative archetypes in sepsis.因果推断可以帮助我们在脓毒症中找到可改变的机制和有意义的原型。
Intensive Care Med. 2024 Dec;50(12):2031-2042. doi: 10.1007/s00134-024-07665-4. Epub 2024 Oct 21.
5
Distinct immune profiles and clinical outcomes in sepsis subphenotypes based on temperature trajectories.基于体温轨迹的脓毒症亚表型的不同免疫特征和临床结局。
Intensive Care Med. 2024 Dec;50(12):2094-2104. doi: 10.1007/s00134-024-07669-0. Epub 2024 Oct 9.
6
Complement system activation: bridging physiology, pathophysiology, and therapy.补体系统激活：连接生理学、病理生理学和治疗学。
Intensive Care Med. 2024 Nov;50(11):1791-1803. doi: 10.1007/s00134-024-07611-4. Epub 2024 Sep 10.
7
Long-term mortality and health-related quality of life with lower versus higher oxygenation targets in intensive care unit patients with COVID-19 and severe hypoxaemia.新型冠状病毒肺炎（COVID-19）合并严重低氧血症的重症监护病房患者中，较低与较高氧合目标的长期死亡率及健康相关生活质量
Intensive Care Med. 2024 Oct;50(10):1603-1613. doi: 10.1007/s00134-024-07613-2. Epub 2024 Sep 5.
8
Multiple indicators of gut dysbiosis predict all-cause and cause-specific mortality in solid organ transplant recipients.肠道菌群失调的多种指标可预测实体器官移植受者的全因和病因特异性死亡率。
Gut. 2024 Sep 9;73(10):1650-1661. doi: 10.1136/gutjnl-2023-331441.
9
Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation.在阿仑单抗诱导后进行自体扩增调节性 T 细胞治疗的晚期治疗在活体供肾移植中是安全的，并有助于减少免疫抑制。
Transplantation. 2024 Nov 1;108(11):2278-2286. doi: 10.1097/TP.0000000000005065. Epub 2024 Oct 22.
10
Non-invasive molecular biomarkers for monitoring solid organ transplantation: A comprehensive overview.用于监测实体器官移植的非侵入性分子生物标志物：全面综述。
Int J Immunogenet. 2024 Apr;51(2):47-62. doi: 10.1111/iji.12654. Epub 2024 Jan 10.